Opportunities and challenges: how to develop pharmaceutical machinery enterprises in the new environment

[editor's point of view of chinapharma.com] unconsciously, one month after the quarter of 2017, the pharmaceutical machinery industry has been caught unprepared by the arrival of various policies and rules and regulations before it has made a good effort A lot of industry data, market summaries and enterprise reports have not been well summarized since the beginning of 2016, 2017 At this time, we need to sort out these lotus like opportunities and challenges in the industry In fact, according to the relevant policies of the pharmaceutical industry issued by the state in 2016, 2017 will be a big year for development It is believed that many pharmaceutical machinery enterprises have also made corresponding plans and Countermeasures for 2017 However, from the perspective of quarterly industry dynamics, it seems that pharmaceutical machinery enterprises are still waiting for the opportunity, or accumulating strength for the future (opportunities and challenges how to develop pharmaceutical machinery enterprises in the new environment picture source: Baidu picture) industry environment: challenges and opportunities coexist in 2017 is considered by many industry personages as the golden development period In the era of great health, the pharmaceutical industry is facing major changes, the health demand is gradually increasing, and the reconstruction of the industrial chain will bring potential opportunities to the pharmaceutical machinery industry Take a closer look at the policies that stir the pharmaceutical industry, such as the consistency evaluation of generic drugs, the law of traditional Chinese medicine, the new rules for the naming of Chinese patent medicine, and the adjustment of the 2017 version of the drug catalog These policies more or less make the pharmaceutical machinery industry in an environment where opportunities and challenges coexist Aiming at the opportunity, seizing the favorable factors and looking at the opportunity, the new regulations on the naming of Chinese patent medicine is the governance of the chaotic phenomenon of "fame is not surprising and does not give up" Many listed pharmaceutical companies have changed their names, including Tongrentang, Guizhou bailing, China new pharmaceutical, China Resources Sanjiu, Tianmu pharmaceutical, Shenwei pharmaceutical, etc This renovation will benefit the pharmaceutical packaging industry A large number of drugs are facing "reshuffle" At that time, the demand for drug packaging machinery can be imagined If the pharmaceutical packaging enterprises can gnaw this bone and provide the mechanical equipment and good product services for pharmaceutical enterprises, the benefits may be far greater than imagination In addition, the adjustment of the new version of the drug catalogue is also a good thing for pharmaceutical machinery There are many highlights in this adjustment: 91 new varieties of children's drugs have been added, support for innovative drugs has been increased, drugs for treatment of major diseases have been focused on, drugs for national negotiations in 2015 have been well connected, and basic drug systems have been strongly supported The State supports pharmaceutical enterprises to carry out new drug research and development, and encourages pharmaceutical enterprises to involve in new fields As the equipment directly contacting with drugs, the successful launch of a new drug is a blessing for patients and an expansion of product demand for pharmaceutical machinery enterprises The opportunities faced by the pharmaceutical machinery industry are not only policy impact, but also market demand With the improvement of living standard, people pay more and more attention to health, and the demand of drug market increases accordingly The demand expansion will lead to the increase of supply Pharmaceutical machinery enterprises should keep pace with the market while carrying out basic production, and aim at the opportunity to hit the demand "red heart" To meet the challenges and take active measures in 2017, although the pharmaceutical machinery industry faces many opportunities, there are also challenges Since last year, the price of raw materials for some drugs has been increased, and the expectation of drug price increase is even stronger in the industry In addition, more stringent quality supervision has also pushed up the production cost of pharmaceutical enterprises to a certain extent In the outline of strategic planning for the development of traditional Chinese medicine (2016-2030), traditional Chinese medicine has been clearly defined as "synergistic effect in the treatment of major diseases", so as to remove traditional Chinese medicine from the main therapeutic products In the next year, the possible post marketing clinical re evaluation of traditional Chinese medicine will sharply reduce the number of traditional Chinese medicine currently on sale, frequent quality problems of traditional Chinese medicine, and reduce people's confidence in domestic traditional Chinese medicine In this regard, the founder of the third-party medical service system mesconlay, Shi lichen, believes that in the next few years, traditional Chinese medicine will be in a very difficult period In addition, the consistency evaluation of generic drugs will lead to a decrease in the number of chemical generic drugs, and the number of pharmaceutical companies that produce and operate chemical generic drugs will also decrease Although the raw materials of some drugs began to rise, the inflated price of drugs has always been a big problem, and the state has taken corresponding measures to curb it Production cost, quality requirements, reduction in the number of pharmaceutical companies All of these bring great challenges to the pharmaceutical machinery industry Faced with such an industry environment, how should pharmaceutical machinery enterprises deal with it? The following several pharmaceutical machinery enterprises can be used for reference On February 21, truking Technology Co., Ltd (hereinafter referred to as "truking technology") and Hunan University of traditional Chinese medicine held a strategic cooperation signing ceremony in Changsha According to the strategic cooperation agreement between the two sides, truking technology and Hunan University of traditional Chinese medicine will carry out multi-level cooperation in technical and non-technical fields At present, in the chemical medicine, API, bio medicine and other pharmaceutical sectors, the proportion of chemical medicine is declining year by year The development of API benefits from the birth of new technology, while bio medicine is making rapid progress, growing exponentially every year Tang Yue, chairman and President of truking technology, analyzed the current situation of the industry and said, "it's embarrassing that traditional Chinese medicine has gone through a detour, but I think it has a huge development space, especially after Tu youyou won the Nobel Prize." For pharmaceutical machinery enterprises, the market space is large, and truking technology aims to improve the quality of traditional Chinese medicine through intelligent production At the annual summary meeting and 2017 planning report meeting of Canaan science and technology, Fang Zheng, general manager, said that 2017 will be based on the development theme of "gathering potential for innovation and following the trend" The enterprise will continue to keep the momentum of national policy, industry and talent, comply with the national 2025 manufacturing and revitalization of traditional Chinese medicine formula, traditional Chinese medicine and other favorable policies, and promote the upgrading of Canaan science and technology strategy In addition, Canaan technology will also take "whole line, intelligence and" as key words, and focus on two institutes and one platform, digital, c2m, integration, sharing, incentive and other work to make a breakthrough, and join hands with subsidiaries to move towards a new level Guangzhou Ruijia Industry Co., Ltd (hereinafter referred to as "Ruijia industry"), an enterprise represented by innovation, has focused on providing various intelligent packaging equipment for the pharmaceutical industry for more than ten years, and customized a complete set of intelligent packaging production line according to the needs of customers Recently, Ruijia industry was approved to set up an expert workstation to promote the research and development of innovative products All three enterprises have carried out relevant cooperation and product innovation according to their own reality and market situation, hoping to achieve breakthroughs in the new year Facing the current situation and future development of the industry, pharmaceutical machinery enterprises should not only embrace the future with a positive attitude, but also make plans for the current situation Pharmaceutical machinery enterprises should combine policy factors and industry trends, treat product production with an innovative perspective, respond to industry competition with rational thinking, and explore a better future with practical strategies.